Gaussian Process Modeling in Conjunction with Individual Patient Simulation Modeling: A Case Study Describing the Calculation of Cost-Effectiveness Ratios for the Treatment of Established Osteoporosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
2. Kanis JA, Brazier JE, Calvert N, Lloyd-Jones M, Stevenson MD. Treatment of established osteoporosis draft report for the NCCHTA. In press.
3. European Commission. Report on osteoporosis in the European Community. Action for prevention. Directorate General for Employment, Industrial Relations and Social Affairs. Directorate V/F.2. Luxembourg, Office for Official Publications of the European Communities; 1998.
5. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical Report Series, No 843. Geneva, Switzerland: World Health Organization; 1994.
6. Chalmers I, Altman DG. Systematic Reviews. London, UK: BMJ; 1995.
7. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluations of healthcare interventions. Health Technol Assess. 1999;3(2).
11. Klotzbeucher CM, Ross PD, Landsman PB, Abbot TA, Berger M. Patients with prior fracture have a increased risk of future fractures: a summary of the literature and statistical synthesis. J BoneMiner Res. 2000;15:721–727.
12. Todd CJ, Freeman C, Camilleri-Ferrante C, et al. Anglian Audit of Hip Fracture 2. Cambridge, UK: Cambridge Health Services Research Group, University of Cambridge; 1999.
14. Netton A, Curtis L. Unit Costs of Health and Social Care 2002. Canterbury, UK: Personal Social Services Research Unit, University of Kent; 2002.
15. Singer BR, McLauchlan CJ, Robinson CM, Christie J. Epidemiology of fracture in 15000 adults. The influence of age and gender. J Bone Joint Surg. 1998;80B:234–238.
17. Department of Health. Policy Appraisal and Health. London, UK: Department of Health; 1995.
19. Glick HA, Briggs AH, Polsky D. Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses. Pharmacoeconomics Outcomes Res. 2001;1:89–100.
22. Haylock R, O’Hagan A. On inference for outputs of computationally expensive computer models with uncertainty on the inputs. In: Bernado JM, Berger JO, DawidAP, SmithAFM, editors. Bayesian Statistics 5. Oxford, UK: Oxford University Press; 1996. p 629–637.
23. Royal Pharmaceutical Society of Great Britain. British National Formulary. BNF43. Available from: http://www.bnf.org. Accessed July 2002.